{"database": "openregs", "table": "documents", "rows": [["FDA-2021-N-0874-0077", "FDA", "FDA-2021-N-0874", "Letter from FDA OC Re Intarcia Therapeutics, Inc. Hearing Request for NDA 209053 ITCA 650 (exenatide in DUROS device)", "Other", "Letter(s)", "2023-04-28T04:00:00Z", 2023, 4, "2023-04-28T04:00:00Z", null, "2023-04-28T12:29:34Z", null, 0, 0, "090000648599a397"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2021-N-0874-0077"], "units": {}, "query_ms": 82.9244889318943, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}